1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Philippines Pharmaceuticals and Healthcare Report Q1 2016

Philippines Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 103 pages

Includes 3 FREE quarterly updates

BMI View: Healthcare access in the Philippines has improved through the expansion of the country'suniversal health insurance scheme and the proposed 2016 government budget will aid further expansion.The country's growing population, increasing disease burden (particularly cancer and cardiovasculardiseases) and rising acceptance of affordable generic drugs, will drive growth in the pharmaceuticalmarket. However, pharmaceutical firms seeking to capture the commercial opportunities from the largeunmet medical need in the Philippines's oncology space will face challenges, as undiagnosed cancer casesremain high and many advanced treatments still require out of pocket payment.

Headline Expenditure Projections
- Pharmaceuticals: PHP145.05bn (USD3.28bn) in 2014, rising to PHP150.44bn (USD3.27bn) in 2015;+3.7% in local currency terms and -0.3% in US dollar terms. Forecast revised downwards slightly fromlast quarter.
- Healthcare: PHP562.90bn (USD12.74bn) in 2014, rising to PHP622.99bn (USD13.54bn) in 2015;+10.7% in local currency terms and +6.4% in US dollar terms. Revised downwards from last quarter.

Table Of Contents

Philippines Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Philippines 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Philippines 2011-2019) 14
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2011-2019) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2011-2019) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2011-2019) 18
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Philippines 2011-2019) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Philippines 2011-2019) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Philippines 2011-2019) 27
OTC Drug Market Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Philippines 2011-2019) 30
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (Philippines 2013-2019) 33
Table: Pharmaceutical Trade Data And Forecasts local currency (Philippines 2013-2019) 34
Industry Risk/Reward Index 35
Asia Pacific Risk/Reward Index 35
Philippines Risk/Reward Index 42
Rewards 42
Risks 43
Regulatory Review 44
Table: History Of Food And Drugs Administration 45
Intellectual Property Regime 50
Pricing Regime 54
Table: Medicines Subject To March 31 2010 Government Mediated Access Price 59
Reimbursement Regime 60
International Cooperation 60
Market Overview 62
Epidemiology 63
Healthcare Sector 64
Table: Healthcare Resources (Philippines 2009-2014) 69
Table: Healthcare Personnel (Philippines 2009-2014) 69
Table: Healthcare Activity (Philippines 2009-2014) 70
Health Insurance 70
Healthcare Sector Financing 72
Medical Tourism 73
Biotechnology And Research 73
Traditional Medicines 75
Clinical Trials 76
Competitive Landscape 77
Pharmaceutical Industry 77
Table: Multinational Market Activity 77
Domestic Pharmaceutical Industry 78
Pharmaceutical Distribution And Retail 79
Table: Overview Of BnB, BNB and P100 Programme 83
Table: Cost Of Generic Drugs In Philippines (PHP) 84
Table: Number Of BnBs And BNBs In Selected Philippine Regions 84
Company Profile 85
GlaxoSmithKline Philippines 85
Novartis 88
Demographic Forecast 92
Table: Population Headline Indicators (Philippines 1990-2025) 93
Table: Key Population Ratios (Philippines 1990-2025) 93
Table: Urban/Rural Population and Life Expectancy (Philippines 1990-2025) 94
Table: Population By Age Group (Philippines 1990-2025) 94
Table: Population By Age Group % (Philippines 1990-2025) 95
Glossary 97
Methodology 99
Pharmaceutical Expenditure Forecast Model 99
Healthcare Expenditure Forecast Model 99
Notes On Methodology 100
Risk/Reward Index Methodology 101
Index Overview 102
Table: Pharmaceutical Risk/Reward Index Indicators 102
Indicator Weightings 103

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.